{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:16:03Z","timestamp":1761765363587},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.medcli.2010.09.011","type":"journal-article","created":{"date-parts":[[2010,11,12]],"date-time":"2010-11-12T04:24:13Z","timestamp":1289535853000},"page":"329-330","source":"Crossref","is-referenced-by-count":4,"title":["Hepatitis fulminante por imatinib en un paciente con leucemia mieloide cr\u00f3nica"],"prefix":"10.1016","volume":"137","author":[{"given":"Cristina","family":"Mart\u00ednez Pascual","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Vald\u00e9s Mas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas Miguel","family":"de la Pe\u00f1a Moral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Miras L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2010.09.011_bib0005","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1182\/blood.V99.6.1928","article-title":"Imatinib induces durable haematologic and cytogenic responses in patient with accelerated phase chronic myeloid leukaemia: results of a phase 2 study","volume":"99","author":"Talpaz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.09.011_bib0010","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1182\/blood-2003-07-2323","article-title":"Fatal hepatic necrosis following imatinib mesylate therapy","volume":"102","author":"Lin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2010.09.011_bib0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ajh.20486","article-title":"Imatinib mesylate as a cause of acute liver failure","volume":"81","author":"Cross","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.medcli.2010.09.011_bib0020","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.3748\/wjg.v13.i48.6608","article-title":"Imatinib-induced fatal acute liver failure","volume":"13","author":"Ridruejo","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.medcli.2010.09.011_bib0025","first-page":"86","article-title":"Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection","volume":"49","author":"Thia","year":"2008","journal-title":"Singapore Med J"},{"key":"10.1016\/j.medcli.2010.09.011_bib0030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.leukres.2009.06.012","article-title":"Nilotinib post-liver transplantation for acute hepatic failure related to imatinib","volume":"33","author":"Perini","year":"2009","journal-title":"Leukemia Research"},{"key":"10.1016\/j.medcli.2010.09.011_bib0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/14639230500236818","article-title":"Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment","volume":"47","author":"Ikeda","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.medcli.2010.09.011_bib0040","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.transproceed.2010.02.038","article-title":"Living donor liver transplantation for acute hepatic failure caused by reactivation of hepatitis B virus infection after chemotherapy for hematologic malignancy: case reports","volume":"42","author":"Kim","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.medcli.2010.09.011_bib0045","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s12185-009-0386-2","article-title":"Chronic myeloid leukaemia patient manifesting fatal hepatitis B virus reactivation during treatment with imatinib rescued by liver transplantation: case report and literature review","volume":"90","author":"Kang","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.medcli.2010.09.011_bib0050","first-page":"112","article-title":"Minimal cross-intolerance between nilotinib and imatinib in patients with imatinib-intolerant chronic myeloid leukaemia in chronic phase (CML-CP) or accelerated phase (CML-AP)","author":"Jabbour","year":"2008","journal-title":"Blood"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577531000936X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577531000936X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T03:15:58Z","timestamp":1559790958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002577531000936X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S002577531000936X"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2010.09.011","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}